Burden of unique and low prevalence somatic mutations correlates with cancer survival.
BRCA1-associated protein (BAP1)-inactivated melanocytic tumors.
J Cutan Pathol. 2019;46(12):965-972 - PMID: 31233225 - DOI: 10.1111/cup.13530
Classifying Melanoma by TERT Promoter Mutational Status.
J Invest Dermatol. 2019;140(2):390-394.e1 - PMID: 31425705 - PMCID: PMC6983338 - DOI: 10.1016/j.jid.2019.06.149
Selective uveal melanoma inhibition with calcium channel blockade.
The X-Linked DDX3X RNA Helicase Dictates Translation Reprogramming and Metastasis in Melanoma.
Cell Rep. 2019;27(12):3573-3586.e7 - PMID: 31216476 - DOI: 10.1016/j.celrep.2019.05.069
Impact of electric scooters to a tertiary emergency department: 8-week review after implementation of a scooter share scheme.
Emerg Med Australas. 2019;31(6):930-934 - PMID: 31423709 - DOI: 10.1111/1742-6723.13356
Growth suppression by dual BRAF(V600E) and NRAS(Q61) oncogene expression is mediated by SPRY4 in melanoma.
Oncogene. 2019;38(18):3504-3520 - PMID: 30651601 - PMCID: PMC6756020 - DOI: 10.1038/s41388-018-0632-2
Use of Targeted Next-Generation Sequencing to Identify Activating Hot Spot Mutations in Cherry Angiomas.
JAMA Dermatol. 2019;155(2):211-215 - PMID: 30601876 - PMCID: PMC6440195 - DOI: 10.1001/jamadermatol.2018.4231
Number needed to screen for presumptive screening diagnoses among first-time SPOTme screening participants (1992-2010).
J Am Acad Dermatol. 2019;82(1):233-234 - PMID: 31228527 - PMCID: PMC7985849 - DOI: 10.1016/j.jaad.2019.06.027
Case-control analysis identifies shared properties of rare germline variation in cancer predisposing genes.
Eur J Hum Genet. 2019;27(5):824-828 - PMID: 30718883 - PMCID: PMC6461796 - DOI: 10.1038/s41431-019-0346-0
Immunotherapeutic strategies for cutaneous squamous cell carcinoma prevention in xeroderma pigmentosum.
Br J Dermatol. 2019;181(5):1095-1097 - PMID: 31102460 - DOI: 10.1111/bjd.18144
11

